AREV Life Sciences Global Corp.
AREVF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $142 | $3,661 | $7,930 | $3,481 |
| - Cash | $2 | $7 | $39 | $0 |
| + Debt | $145 | $145 | $62 | $29 |
| Enterprise Value | $286 | $3,799 | $7,953 | $3,509 |
| Revenue | $0 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$14 | -$14 | -$14 | -$22 |
| % Margin | – | – | – | -299.9% |
| EBITDA | -$14 | -$106 | -$155 | $110 |
| % Margin | – | – | – | 1,519.8% |
| Net Income | -$29 | -$121 | -$169 | $80 |
| % Margin | – | – | – | 1,103.9% |
| EPS Diluted | -0.001 | -0.004 | -0.005 | 0.003 |
| % Growth | 76.3% | 28.3% | -312% | – |
| Operating Cash Flow | -$6 | -$116 | -$25 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$6 | -$116 | -$25 | -$7 |